LBNP Tolerance With Skin Warming After Exercise Cold Stress

NCT ID: NCT06279897

Last Updated: 2025-03-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-24

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Assess the effect of skin rewarming during lower body negative pressure upon arterial blood pressure and tolerance to simulated blood loss after exercise in the cold.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Individuals who have experienced a hemorrhagic insult are often wrapped in a warm blanket. In individuals who have exercise in a cold environment, it is unknown how this skin warming influence tolerance to simulated blood loss and whether there is an optimal temperature to warm the skin up to in order to lower blood pressure (permissive hypotension).

After an initial study visit to examine exercise capacity (Visit 1), participants will complete four trials (Visits 2 through 5) After exercise in a cold environment, participants will have cold skin temperatures (\~82°F; Visit 2). Researchers will examine how increasing skin temperature to normal (\~90°F; Visit 3), warm (93°F; Visit 4) and hot (95°F; Visit 5) influences arterial blood pressure and tolerance to simulated blood loss compared to when the skin remains cold.

This project will test the hypothesis that skin rewarming to \~95°F lowers arterial blood pressure without impairing tolerance to simulated blood loss (lower body negative pressure; LBNP) relative to when the skin is kept cold (82°F).

Primary data include core and skin temperatures, arterial blood pressure and LBNP tolerance time. Secondary variables include skin blood flow and heart rate. After completing visit 1 first, all participants will complete visits 2 through 5 in a randomized order and participants are blinded. The order will be counterbalanced between participants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Pressure Blood Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Participants will complete trial 1 at the beginning of the study. Participants will then complete trials 2 through 5 in a random, counterbalanced order.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Participants are blinded to the skin temperature control.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Skin Temperature Control During Simulated Blood Loss After Exercise Cold Stress

After exercise in the cold and participants skin will remain cold (\~82°F), be returned to normal (\~90°F), be slightly warmed (\~93°F) or heated (\~95°F) sixty seconds after the onset of LBNP.

Group Type EXPERIMENTAL

Skin Surface Rewarming

Intervention Type OTHER

Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will be increased to \~90°F and held here for the duration of the LBNP test.

Skin Surface Warming

Intervention Type OTHER

Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will be increased to \~93°F and held here for the duration of the LBNP test.

Skin Surface Heating

Intervention Type OTHER

Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will be increased to \~95°F and held here for the duration of the LBNP test.

Skin Surface Cooling

Intervention Type OTHER

Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will remain lowered to \~82°F for the duration of the LBNP test.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Skin Surface Rewarming

Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will be increased to \~90°F and held here for the duration of the LBNP test.

Intervention Type OTHER

Skin Surface Warming

Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will be increased to \~93°F and held here for the duration of the LBNP test.

Intervention Type OTHER

Skin Surface Heating

Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will be increased to \~95°F and held here for the duration of the LBNP test.

Intervention Type OTHER

Skin Surface Cooling

Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will remain lowered to \~82°F for the duration of the LBNP test.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Normothermic Trial Warm Trial Hot Trial Cold Trial Control Trial

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 and 40 years old
* free of known disease and illness
* Speak English
* Systolic blood pressure \<140mmHg
* Diastolic blood pressure \<90 mmHg

Exclusion Criteria

* Currently pregnant or breast feeding
* Individuals with diagnosed with cardiac, respiratory, neurological and/or metabolic illness or disease.
* Currently taking prescribed or over the counter medications known to influence the cardiovascular, pulmonary, renal and/or central nervous system.
* Current use of tobacco or nicotine products
* Body mass\< 80 pounds body weight
* Appendectomy
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Colorado, Colorado Springs

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

James Pearson

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

James Pearson, PhD

Role: PRINCIPAL_INVESTIGATOR

Univeristy of Colorado Colorado Springs

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Colorado Colorado Springs

Colorado Springs, Colorado, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-068

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Skin Wetting in Burn Survivors
NCT06529757 RECRUITING NA